2022
DOI: 10.1183/13993003.02288-2021
|View full text |Cite
|
Sign up to set email alerts
|

T2-high asthma phenotypes across lifespan

Abstract: RationaleIn adults, personalised asthma treatment targets patients with T2-high and eosinophilic asthma phenotypes. It is unclear whether such classification is achievable in children.ObjectivesTo define T2-high asthma with easily accessible biomarkers and compare resulting phenotypes across all ages.MethodsIn the multicenter clinical ALL Age Asthma Cohort (ALLIANCE), 1125 participants (n=776 asthmatics, n=349 controls) were recruited and followed for 2 years (1 year in adults). Extensive clinical characterisa… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
28
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 43 publications
(29 citation statements)
references
References 33 publications
1
28
0
Order By: Relevance
“…Using readily available biomarkers, people with T2 high asthma can be identified at all ages, and different phenotypes can be depicted. 42 The level of C4Ma3 is elevated in the phenotype of severe and aggravating allergic asthma, and C4Ma3 can be used as a new biomarker to predict the response to anti IgE treatment. 43 IgA positive memory B cells are significantly increased in patients with asthma and small airway dysfunction, which indicates the direction for future selection of asthma prevention and treatment strategies guided by B cells.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Using readily available biomarkers, people with T2 high asthma can be identified at all ages, and different phenotypes can be depicted. 42 The level of C4Ma3 is elevated in the phenotype of severe and aggravating allergic asthma, and C4Ma3 can be used as a new biomarker to predict the response to anti IgE treatment. 43 IgA positive memory B cells are significantly increased in patients with asthma and small airway dysfunction, which indicates the direction for future selection of asthma prevention and treatment strategies guided by B cells.…”
Section: Discussionmentioning
confidence: 99%
“…It is unclear whether this classification is feasible for children. Using readily available biomarkers, people with T2 high asthma can be identified at all ages, and different phenotypes can be depicted 42 . The level of C4Ma3 is elevated in the phenotype of severe and aggravating allergic asthma, and C4Ma3 can be used as a new biomarker to predict the response to anti IgE treatment 43 .…”
Section: Discussionmentioning
confidence: 99%
“…2,4 More recently, the field has adopted a distinction based on the presence ("T2-high") or absence ("T2-low") of substantial type-2 inflammation in the airways. 3,16 T2high asthma mainly involves allergic disease types and affects most children with asthma as well as approximately 50% of adult patients.…”
Section: The Pathophys I Ology Of a S Thmamentioning
confidence: 99%
“…However, this classification turned out to be an oversimplification, 15 as extensive inflammatory and clinical heterogeneity exists among asthma patients that is not captured by the allergic/non‐allergic dichotomy 2,4 . More recently, the field has adopted a distinction based on the presence (“T2‐high”) or absence (“T2‐low”) of substantial type‐2 inflammation in the airways 3,16 . T2‐high asthma mainly involves allergic disease types and affects most children with asthma as well as approximately 50% of adult patients.…”
Section: The Pathophysiology Of Asthmamentioning
confidence: 99%
“…5,6 In industrialized countries, children are more likely to have high Th2 immunity -and thus T2-high asthma-than adults. 6,7 During childhood, high Th2 immunity is often defined by sensitization to allergens (atopy), a high total IgE, and peripheral blood eosinophilia.…”
Section: Introduction Asthma Affects Approximately 252 Million People...mentioning
confidence: 99%